Skip to main content

Apheresis

  • Chapter

Abstract

The term “apheresis” is derived from a Greek word meaning “removal.” In its most general sense, apheresis refers to techniques for large-scale removal of selected components of the blood. “Plasmapheresis” refers to removal of plasma, “erythrocytapheresis” to removal of red blood cells, and “leukapheresis” to removal of white blood cells. This chapter will give an overview of apheresis techniques in general, describe some of the issues that are unique to the application of apheresis techniques in Pediatrics, and will review indications for use of apheresis in patients with renal disease.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Chopek M, McCullough J. Protein and Biochemical Changes During Plasma Exchange. Washington: AABB Press, 1980.

    Google Scholar 

  2. Strauss R, McLeod B. Adverse Reactions to Therapeutic Apheresis. Bethesda, MD: AABB Press, 1996.

    Google Scholar 

  3. Dzik WH, Kirkley SA. Citrate toxicity during massive blood transfusion. Transfus Med Rev. 1988;2(2):76–94.

    Article  PubMed  CAS  Google Scholar 

  4. Olson PR, Cox C, McCullough J. Laboratory and clinical effects of the infusion of ACD solution during plateletpheresis. Vox Sang. 1977;33(2):79–87.

    Article  PubMed  CAS  Google Scholar 

  5. Szymanski IO. Ionized calcium during plateletpheresis. Transfusion. 1878;18(6):701–8.

    Article  Google Scholar 

  6. George JN, Woolf SH, Raskob GE, Wasser JS, Aledort LM, Ballern PJ, Blanchette VS, Bussel JB, Cines DB, Kelton JG, Lichtin AE, McMillan R, Okerbloom JA, Regan DH, Warrier I. Idiopathic thrombocytopenic purpura: a practice guideline developed by explicit methods for the American Society of Hematology. Blood. 1996;88(l):3–40.

    PubMed  CAS  Google Scholar 

  7. Snyder HW, Jr. Cochran SK, Balint JP, Jr, Bertram JH, Mittelman A, Guthrie TH, Jr., Jones FR. Experience with protein A-immunoadsorption in treatment-resistant adult immune thrombocytopenic purpura. Blood. 1992;79(9):2237–45.

    PubMed  Google Scholar 

  8. Furst D, Felson D, Thoren G, Gendreau RM. Immunoadsorption for the treatment of rheumatoid arthritis: final results of a randomized trial. Prosorba Trial Investigators. Ther Apher. 2000;4(5):363–73.

    CAS  Google Scholar 

  9. Hughes LB, Moreland LW. New therapeutic approaches to the management of rheumatoid arthritis. BioDrugs. 2001;15(6):379–93.

    Article  PubMed  CAS  Google Scholar 

  10. Freiburghaus C, Berntorp E, Ekman M, Gunnarsson M, Kjellberg BM, Nilsson IM. Immunoadsorption for removal of inhibitors: update on treatments in Malmo-Lund between 1980 and 1995. Haemophilia. 1998;4(1):16–20.

    Article  PubMed  CAS  Google Scholar 

  11. Nilsson IM, Freiburghaus C. Apheresis. Adv Exp Med Biol. 1995;386:175–84.

    Article  PubMed  CAS  Google Scholar 

  12. Uehlinger J, Button GR, McCarthy J, Forster A, Watt R, Aledort LM. Immunoadsorption for coagulation factor inhibitors. Transfusion. 1991;31(3):265–9.

    Article  PubMed  CAS  Google Scholar 

  13. Bohmig GA, Regele H, Saemann MD, Exner M, Druml W, Kovarik J, Horl WH, Zlabinger GJ, Watschinger B. Role of humoral immune reactions as target for antirejection therapy in recipients of a spousal-donor kidney graft. Am J Kidney Dis. 2000;35(4):667–73.

    Article  PubMed  CAS  Google Scholar 

  14. Braun N, Kadar JG, Risler T. Therapeutic immunoadsorption-its role in clinical practice. Transfus Sci. 1998;19(Suppl):65–9.

    Article  PubMed  Google Scholar 

  15. Bueno D, Jr, Sevigny J, Kaplan AA. Extracorporeal treatment of thrombotic microangiopathy: a ten year experience. Ther Apher. 1999;3(4):294–7.

    Article  PubMed  Google Scholar 

  16. Bygren P, Freiburghaus C, Lindholm T, Simonsen O, Thysell H, Wieslander J. Goodpasture’s syndrome treated with staphylococcal protein A immunoadsorption. Lancet. 1985;2(8467):1295–6.

    Article  PubMed  CAS  Google Scholar 

  17. Dantal J, Bigot E, Bogers W, Testa A, Kriaa F, Jacques Y, Hurault de Ligny B, Niaudet P, Charpentier B, Soulillou JP. Effect of plasma protein adsorption on protein excretion in kidney-transplant recipients with recurrent nephrotic syndrome. N Engl J Med. 1994;330(1):7–14.

    Article  PubMed  CAS  Google Scholar 

  18. Esnault V, Bignon JD, Testa A, Preud’homme JL, Vergracht A, Soulillou JP. Effect of protein A immunoadsorption on panel lymphocyte reactivity in hyperimmunized patients awaiting a kidney graft. Transplantation. 1990;50(3):449–53.

    Article  PubMed  CAS  Google Scholar 

  19. Esnault VL, Besnier D, Testa A, Coville P, Simon P, Subra JF, Audrain MA. Effect of protein A immunoadsorption in nephrotic syndrome of various etiologies. J Am Soc Nephrol. 1999;10(9): 2014–17.

    PubMed  CAS  Google Scholar 

  20. Haas M, Bohmig GA, Leko-Mohr Z, Exner M, Regele H, Derfler K, Horl WH, Druml W. Perioperative immunoadsorption in sensitized renal transplant recipients. Nephrol Dial Transplant. 2002;17(8): 1503–8.

    Article  PubMed  Google Scholar 

  21. Hickstein H, Korten G, Bast R, Barz D, Nizze H, Schmidt R. Immunoadsorption of sensitized kidney transplant candidates immediately prior to surgery. Clin Transplant, 2002;16(2):97–101.

    Article  PubMed  CAS  Google Scholar 

  22. Hiesse C, Kriaa F, Rousseau P, Farahmand H, Bismuth A, Fries D, Charpentier B. Immunoadsorption of anti-HLA antibodies for highly sensitized patients awaiting renal transplantation. Nephrol Dial Transplant. 1992;7(9):944–51.

    PubMed  CAS  Google Scholar 

  23. Juckett M, Perry EH, Daniels BS, Weisdorf DJ. Hemolytic uremic syndrome following bone marrow transplantation. Bone Marrow Transplant. 1991;7(5):405–9.

    PubMed  CAS  Google Scholar 

  24. Mastrangelo F, Pretagostini R, Berloco P, Poli L, Cinti P, Patruno P, Alfonso L, Pompei L, Carboni F, Rizzelli S et al. Immunoadsorption with protein A in humoral acute rejection of kidney transplants: multicenter experience. Transplant Proc. 1995;27(l):892–5.

    PubMed  CAS  Google Scholar 

  25. Matic G, Bosch T, Ramlow W. Background and indications for protein A-based extracorporeal immunoadsorption. Ther Apher. 2001;5(5):394–403.

    Article  PubMed  CAS  Google Scholar 

  26. Mittelman A, Bertram J, Henry DH, Snyder HW, Jr., Messerschmidt GL, Ciavarella D, Ainsworth S, Kiprov D, Arlin Z. Treatment of patients with HIV thrombocytopenia and hemolytic uremic syndrome with protein A (Prosorba column) immunoadsorption. Semin Hematol. 1989;26(2Suppl 1):15–18.

    PubMed  CAS  Google Scholar 

  27. Pretagostini R, Berloco P, Poli L, Cinti P, Di Nicuolo A, De Simone P, Colonnello M, Salerno A, Alfani D, Cortesini R. Immunoadsorption with protein A in humoral rejection of kidney transplants. Asaio J. 1996;42(5):M645–8.

    Article  PubMed  CAS  Google Scholar 

  28. Snyder HW, Jr, Mittelman A, Oral A, Messerschmidt GL, Henry DH, Korec S, Bertram JH, Guthrie TH, Jr. Ciavarella D, Wuest D et al. Treatment of cancer chemotherapy-associated thrombotic thrombocytopenic purpura/hemolytic uremic syndrome by protein A immunoadsorption of plasma. Cancer. 1993;71(5):1882–92.

    Article  PubMed  Google Scholar 

  29. Watson PR, Guthrie TH, Jr, Caruana RJ. Cisplatin-associated hemolytic-uremic syndrome. Successful treatment with a staphylococcal protein A column. Cancer. 1989;64(7):1400–3.

    CAS  Google Scholar 

  30. Parhofer KG, Geiss HC, Schwandt P. Efficacy of different low-density lipoprotein apheresis methods. Ther Apher. 2000;4(5):382–5.

    Article  PubMed  CAS  Google Scholar 

  31. Schmaldienst S, Banyai S, Stulnig TM, Heinz G, Jansen M, Horl WH, Derfler K. Prospective randomised cross-over comparison of three LDL-apheresis systems in statin pretreated patients with familial hypercholesterolaemia. Atherosclerosis. 2000;151(2):493–9.

    Article  PubMed  CAS  Google Scholar 

  32. Vella A, Pineda AA, O’Brien T. Low-density lipoprotein apheresis for the treatment of refractory hyperlipidemia. Mayo Clin Proc. 2001;76(10):1039–46.

    Article  PubMed  CAS  Google Scholar 

  33. Adams DM, Schultz WH, Ware RE, Kinney TR. Erythrocytapheresis can reduce iron overload and prevent the need for chelation therapy in chronically transfused pediatric patients. J Pediatr Hematol Oncol. 1996;18(1):46–50.

    Article  PubMed  CAS  Google Scholar 

  34. Kim HC, Dugan NP, Silber JH, Martin MB, Schwartz E, Ohene-Frempong K, Cohen, AR. Erythrocytapheresis therapy to reduce iron overload in chronically transfused patients with sickle cell disease. Blood. 1994;83(4):1136–42.

    PubMed  CAS  Google Scholar 

  35. Maurer HS, Steinherz PG, Gaynon PS, Finklestein JZ, Sather HN, Reaman GH, Bleyer WA, Hammond GD. The effect of initial management of hyperleukocytosis on early complications and outcome of children with acute lymphoblastic leukemia. J Clin Oncol. 1988;6(9):1425–32.

    PubMed  CAS  Google Scholar 

  36. Rowe JM, Lichtman MA. Hyperleukocytosis and leukostasis: common features of childhood chronic myelogenous leukemia. Blood. 1984;63(5):1230–4.

    PubMed  CAS  Google Scholar 

  37. Stemmler J, Wittmann GW, Hacker U, Heinemann V. Leukapheresis in chronic myelomonocytic leukemia with leukostasis syndrome: elevated serum lactate levels as an early sign of microcirculation failure. Leuk Lymphoma. 2002;43(7): 1427–30.

    Article  PubMed  CAS  Google Scholar 

  38. Steeper TA, Smith JA, McCullough J. Therapeutic cytapheresis using the Fenwal CS-3000 blood cell separator. Vox Sang. 1985;48(4): 193–200.

    Article  PubMed  CAS  Google Scholar 

  39. Costanzo-Nordin MR, Hubbell EA, O’Sullivan EJ, Johnson MR, Mullen GM, Heroux AL, Kao WG, McManus BM, Pifarre R, Robinson JA. Photopheresis versus corticosteroids in the therapy of heart transplant rejection. Preliminary clinical report. Circulation. 1992;86(5 Supp 1): II242–50.

    PubMed  CAS  Google Scholar 

  40. Meiser BM, Kur F, Reichenspurner H, Wagner F, Boos KS, Vielhauer S, Weiss M, Rohrbach H, Kreuzer E, Uberfuhr et al. Reduction of the incidence of rejection by adjunct immunosuppression with photochemotherapy after heart transplantation. Transplantation. 1994;57(4):563–8.

    PubMed  CAS  Google Scholar 

  41. Dall’Amico R, Rossetti F, Zulian F, Montini G, Murer L, Andreetta B, Messina C, Baraldi E, Montesco MC, Dini G, Locatelli F, Argiolu F, Zacchello G. Photopheresis in paediatric patients with drug-resistant chronic graft-versus-host disease. Br J Haematol. 1997;97(4):848–54.

    Article  CAS  Google Scholar 

  42. Rossetti F, DaH’Amico R, Crovetti G, Messina C, Montini G, Dini G, Locatelli F, Argiolu F, Miniero R, Zacchello G. Extracorporeal photochemotherapy for the treatment of graft-versus-host disease. Bone Marrow Transplant. 1996;18(Suppl 2):175–81.

    PubMed  Google Scholar 

  43. Adami R. Therapeutic thrombocytapheresis: a review of 132 patients. Int J Artif Organs. 1993;16(Suppl 5):183–4.

    PubMed  Google Scholar 

  44. Baron BW, Mick R, Baron JM. Combined plateletpheresis and cytotoxic chemotherapy for symptomatic thrombocytosis in myeloproliferative disorders. Cancer. 1993;72(4):1209–18.

    Article  PubMed  CAS  Google Scholar 

  45. Liumbruno G, Centoni PE, Ceretelli S, Sodini ML. Rapid reduction of platelet numbers in thrombocytosis. Ther Apher. 2000;4(5):374–6.

    Article  PubMed  CAS  Google Scholar 

  46. Renner D, Queisser U, Martinez C, Queisser W. Treatment of excessive thrombocythemia in chronic myeloid leukemia by thrombocytopheresis and intravenous Thio-TEPA. Onkologie. 1987;10(5):324–6.

    Article  PubMed  CAS  Google Scholar 

  47. Ullrich H, Kadar J, Waxenberger Y, Hohe R, Saueressig C, Heyder M, Wiebecke D. [Therapeutic thrombocytapheresis in patients with myeloproliferative diseases with the cell separators Fresenius AS 104 and Cobe Spectra: biocompatibility and safety]. Beitr Infusionsther. 1992;30: 311–14.

    PubMed  CAS  Google Scholar 

  48. Gerhardt RE, Ntoso KA, Koethe JD, Lodge S, Wolf CJ. Acute plasma separation with hemodialysis equipment. J Am Soc Nephrol. 1992;2(9):1455–8.

    PubMed  CAS  Google Scholar 

  49. Price, CA. Therapeutic plasma exchange in a dialysis unit. Anna J. 1987;14(2): 103–8.

    Article  PubMed  CAS  Google Scholar 

  50. Nadler SB, Hidalgo JU, Bloch T. Prediction of blood volume in normal human adults. Surgery, 1962;51:224.

    PubMed  Google Scholar 

  51. Kim HC. Therapeutic pediatric apheresis. J Clin Apheresis. 2000;15(1-2):129–57

    Article  PubMed  CAS  Google Scholar 

  52. McLeod BC. Clinical Applications of Therapeutic Apheresis. J Clin Apheresis. 2000;15:1–5.

    Article  PubMed  CAS  Google Scholar 

  53. Owen HG, Brecher ME. Atypical reactions associated with use of angiotensin-converting enzyme inhibitors and apheresis. Transfusion. 1994;34:891–4.

    Article  PubMed  CAS  Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2004 Springer Science+Business Media Dordrecht

About this chapter

Cite this chapter

Friedman, D.F., Kim, H.C. (2004). Apheresis. In: Warady, B.A., Schaefer, F.S., Fine, R.N., Alexander, S.R. (eds) Pediatric Dialysis. Springer, Dordrecht. https://doi.org/10.1007/978-94-007-1031-3_38

Download citation

  • DOI: https://doi.org/10.1007/978-94-007-1031-3_38

  • Publisher Name: Springer, Dordrecht

  • Print ISBN: 978-94-010-3770-9

  • Online ISBN: 978-94-007-1031-3

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics